Loss of CD127 expression defines an expansion of effector CD8+ T cells in HIV-infected individuals

M Paiardini, B Cervasi, H Albrecht… - The Journal of …, 2005 - journals.aai.org
M Paiardini, B Cervasi, H Albrecht, A Muthukumar, R Dunham, S Gordon, H Radziewicz…
The Journal of Immunology, 2005journals.aai.org
The immunodeficiency that follows HIV infection is related to the virus-mediated killing of
infected CD4+ T cells, the chronic activation of the immune system, and the impairment of T
cell production. In this study we show that in HIV-infected individuals the loss of IL-7R
(CD127) expression defines the expansion of a subset of CD8+ T cells, specific for HIV as
well as other Ags, that show phenotypic (ie, loss of CCR7 and CD62 ligand expression with
enrichment in activated and/or proliferating cells) as well as functional (ie, production of IFN …
Abstract
The immunodeficiency that follows HIV infection is related to the virus-mediated killing of infected CD4+ T cells, the chronic activation of the immune system, and the impairment of T cell production. In this study we show that in HIV-infected individuals the loss of IL-7R (CD127) expression defines the expansion of a subset of CD8+ T cells, specific for HIV as well as other Ags, that show phenotypic (ie, loss of CCR7 and CD62 ligand expression with enrichment in activated and/or proliferating cells) as well as functional (ie, production of IFN-γ, but not IL-2, decreased ex vivo proliferative potential and increased susceptibility to apoptosis) features of effector T cells. Importantly, in HIV-infected individuals the levels of CD8+ CD127− T cells are directly correlated with the main markers of disease progression (ie, plasma viremia and CD4+ T cell depletion) as well as with the indices of overall T cell activation. In all, these results identify the expansion of CD8+ CD127− effector-like T cells as a novel feature of the HIV-associated immune perturbation. Further studies are thus warranted to determine whether measurements of CD127 expression on CD8+ T cells may be useful in the clinical management of HIV-infected individuals.
journals.aai.org